Derek Lindsay
Vorstandsvorsitzender bei Redx Oncology Ltd.
Aktive Positionen von Derek Lindsay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Vorstandsvorsitzender | - | - |
Infex Therapeutics Ltd.
Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Geschäftsführer | - | - |
Nhs Ayrshire & Arran
Nhs Ayrshire & Arran Hospital/Nursing ManagementHealth Services NHS Ayrshire & Arran is a healthcare provider that offers a wide range of high-quality health services to a population of approximately 367,000 people. NHS Ayrshire & Arran also has a duty to protect public health throughout Ayrshire and Arran. The private company is based in Ayrshire, UK, and has subsidiaries in the United Kingdom. The British company has invested in modern hospitals and community facilities, and its highly trained and qualified staff provide healthcare services. The CEO of the company is Claire Burden. | Direktor/Vorstandsmitglied | - | - |
Finanzdirektor/CFO | 01.04.2000 | - |
Karriereverlauf von Derek Lindsay
Ehemalige bekannte Positionen von Derek Lindsay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REDX PHARMA PLC | Direktor/Vorstandsmitglied | 01.09.2010 | 09.05.2016 |
Geschäftsführer | 01.09.2010 | 31.12.2017 | |
Technik-/Wissenschafts-/F&E-Leiter | 14.10.2010 | 14.01.2015 | |
Gründer | 01.09.2010 | 31.12.2017 | |
Britest Ltd. | Corporate Officer/Principal | 14.10.2010 | 31.12.2012 |
Avecia Pharmaceuticals Ltd.
Avecia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Avecia Pharmaceuticals Ltd. used to manufacture pharmaceutical ingredients. The company was focused on providing custom chemical synthesis and manufacturing services for the pharmaceutical and biotechnology companies. Avecia Pharmaceuticals was headquartered in Manchester, UK | Technik-/Wissenschafts-/F&E-Leiter | 26.03.2013 | - |
Corporate Officer/Principal | - | 26.03.2013 |
Statistik
International
Vereinigtes Königreich | 7 |
Operativ
Director/Board Member | 2 |
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 5 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REDX PHARMA PLC | Health Technology |
Private Unternehmen | 5 |
---|---|
Britest Ltd. | |
Avecia Pharmaceuticals Ltd.
Avecia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Avecia Pharmaceuticals Ltd. used to manufacture pharmaceutical ingredients. The company was focused on providing custom chemical synthesis and manufacturing services for the pharmaceutical and biotechnology companies. Avecia Pharmaceuticals was headquartered in Manchester, UK | Health Technology |
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Health Technology |
Infex Therapeutics Ltd.
Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Health Technology |
Nhs Ayrshire & Arran
Nhs Ayrshire & Arran Hospital/Nursing ManagementHealth Services NHS Ayrshire & Arran is a healthcare provider that offers a wide range of high-quality health services to a population of approximately 367,000 people. NHS Ayrshire & Arran also has a duty to protect public health throughout Ayrshire and Arran. The private company is based in Ayrshire, UK, and has subsidiaries in the United Kingdom. The British company has invested in modern hospitals and community facilities, and its highly trained and qualified staff provide healthcare services. The CEO of the company is Claire Burden. | Health Services |
- Börse
- Insiders
- Derek Lindsay
- Erfahrung